LORAZEPAM

Generic: LORAZEPAM

Aurolife Pharma LLCManufacturer
ORALRoute
LORAZEPAMActive Substance
2017-12-22Original Approval

LORAZEPAM is FDA application ANDA203572, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2022-07-11
Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heig

Failed Impurities/Degradation Specifications: Out-of-specification results observed for total relate

Class II2017-09-28
Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004

Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets o

Class II2022-07-11
Lorazepam Injection, USP, 4mg/mL, 1 mL vial, 25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heig

Failed Impurities/Degradation Specifications: Out-of-specification results observed for total relate

Class II2025-07-22
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, N

Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds

Class II2022-07-11
Lorazepam Injection, USP, 2mg/mL, 1 mL vial, 25 vials per carton, RX Only, Manufactured by West-Ward Eatontown, NJ 0772

Failed Impurities/Degradation Specifications: Out-of-specification results observed for total relate

Class II2023-05-11
Lorazepam Injection, USP, 2mg/mL, 1 mL vial (NDC 0641-6044-01), packaged in 25 x 1 mL Vials per carton (NDC 0641-6044-25

Failed Impurities/Degradation Specifications: Out-of-specification results for total related compoun

Class I2017-08-03
Lorazepam Oral Concentrate, USP, 2 mg/mL, 30 mL bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Branchburg, NJ

Defective Delivery System: the dropper measurement markings may be reversed, shifted or missing.

Top Reported Reactions

1
DRUG INEFFECTIVE
9,354 reports
2
FATIGUE
9,067 reports
3
NAUSEA
8,906 reports
4
OFF LABEL USE
7,926 reports
5
DIARRHOEA
7,262 reports
6
DYSPNOEA
6,330 reports
7
VOMITING
6,047 reports
8
HEADACHE
5,884 reports
9
DIZZINESS
5,685 reports
10
ANXIETY
5,680 reports